# Chemotherapy-induced cardiotoxicity and mitigation

{
  "id": "T11535",
  "title": "Chemotherapy-induced cardiotoxicity and mitigation",
  "url": "/topics/T11535",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "981845be8c37c5b8",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "36249009656342958",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2705,
    11535
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the cardiotoxic effects of various cancer treatments, particularly anthracyclines and related drugs like doxorubicin and trastuzumab. It explores the molecular mechanisms, pharmacologic developments, early detection, prevention, and management of cardiotoxicity in cancer patients. The papers also discuss the long-term cardiovascular complications and survival outcomes in individuals undergoing these treatments.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T11535

No owner-reviewed local answer yet.